Stellate Therapeutics Inc.
PrivateLast Round
VC Round
May 18, 2021
Company Overview
Stellate Therapeutics Inc. operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a VC Round in May 2021.
Stellate Therapeutics Inc. is a biotechnology company that develops small molecules produced by human gut bacteria into first-in-class personalized therapies for neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stellate Therapeutics Inc. Comparables
Compare Stellate Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Enterin | 85% | |
| Vertero Therapeutics | 82% | |
| Holobiome | 74% |
For institutional investors. Book with your work email.
Stellate Therapeutics Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Stellate Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| eureKARE | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 12, 2024
Monthly visitors increased 252% MoM, reaching 327.
- May 18, 2021
Led by eureKARE
For institutional investors. Book with your work email.
Stellate Therapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Stellate Therapeutics Inc.'s valuation, stock price, and market status.
Is Stellate Therapeutics Inc. a public or private company?
Stellate Therapeutics Inc. is a private company.
What is the current stock price of Stellate Therapeutics Inc.?
Stellate Therapeutics Inc. is a private company, so its shares have no public market price. Caplight tracks Stellate Therapeutics Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Stellate Therapeutics Inc. worth (valuation)?
Valuation information for Stellate Therapeutics Inc. is not publicly available.
Can I buy Stellate Therapeutics Inc. stock?
Stellate Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Stellate Therapeutics Inc.'s last funding round?
Stellate Therapeutics Inc.'s most recent funding round was VC Round on May 18, 2021.
Who are the main investors in Stellate Therapeutics Inc.?
Key investors in Stellate Therapeutics Inc. include eureKARE.
Will Stellate Therapeutics Inc. IPO soon?
No public IPO plans have been announced for Stellate Therapeutics Inc..
How can I track Stellate Therapeutics Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Stellate Therapeutics Inc.'s shares on secondary markets.